Skip to content

VISION HEALTHCARE

Active Risk: not assessed
Public limited companyfounded 20178 yrs activeNijverheidslaan 3, 8560 Wevelgem, BelgiumKBO/BCE: BE 0685.849.188
Summary

VISION HEALTHCARE has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2024 annual accounts show equity of €122.56M and a net result of €-5.92M. Equity is growing by ~11.9% per year across the filed fiscal years. Its solvency ranks better than 60% of 85 sector peers (fiscal year 2024). The company has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals.

Watch
Print / PDF

Checked score

Outside the general model
Holding: general score not applicable
The company has a registered holding activity and financial fixed assets account for more than half of its assets. The general operating-company model is unsuitable for this profile, so we show no financial axes either. Filed figures remain available.
Credit check for your own amount and term

Signals

1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 15-05-2025, 77 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
not confirmed
2024
77 d early
2023
23 d late
2022
21 d late
2021
60 d early
2020
45 d early
2019
67 d early
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, full schema, statutory accounts

Turnover
€11.99M▲ 4.8%
2023 · €11.43M
2018: €1.44M 2020: €6.88M 2021: €9.50M 2022: €11.24M 2023: €11.43M
2018 → 2024
EBIT margin
-9.5%▲ 4.8pp
2023 · -14.2%
2018: -41.0% 2020: -8.4% 2021: -10.5% 2022: -1.6% 2023: -14.2%
2018 → 2024
Net result
€-5.92M▼ 198%
2023 · €-1.99M
2018: €-375k 2020: €1.09M 2021: €-14.75M 2022: €1.43M 2023: €-1.99M
2018 → 2024
Working capital
€13.83M▼ 11.2%
2023 · €15.58M
2018: €2.13M 2020: €6.03M 2021: €7.88M 2022: €10.17M 2023: €15.58M
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20202021202220232024Trend
Turnover€6.88M-€9.50M▲ 38.1%€11.24M▲ 18.4%€11.43M▲ 1.7%€11.99M▲ 4.8%
Equity€85.36M-€120.04M▲ 40.6%€130.47M▲ 8.7%€128.48M▼ 1.5%€122.56M▼ 4.6%
Operating result€-576k-€-998k▼ 73.1%€-178k▲ 82.1%€-1.63M▼ 813%€-1.14M▲ 30.2%
Net result€1.09M-€-14.75M€1.43M€-1.99M€-5.92M▼ 198%
Result per fiscal year
Operating resultNet result
€-15.00M€-10.00M€-5.00M€0Operating result 2020: €-576k€-576kNet result 2020: €1.09M€1.09MOperating result 2021: €-998k€-998kNet result 2021: €-14.75M€-14.75MOperating result 2022: €-178k€-178kNet result 2022: €1.43M€1.43MOperating result 2023: €-1.63M€-1.63MNet result 2023: €-1.99M€-1.99MOperating result 2024: €-1.14M€-1.14MNet result 2024: €-5.92M€-5.92M20202021202220232024€-6M€-4M€-2M€0€2MOperating result 2022: €-178k€-178kNet result 2022: €1.43M€1.4MOperating result 2023: €-1.63M€-1.6MNet result 2023: €-1.99M€-2MOperating result 2024: €-1.14M€-1.1MNet result 2024: €-5.92M€-5.9M202220232024
The operating result stays negative: a loss of €1.14M in 2024 against €1.63M in 2023; the loss shrinks.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €253.86M
Fixed assets €239.00M ▼ 6.0%
Current assets €14.86M ▼ 7.9%
Equity and liabilities €253.86M
Equity €122.56M ▼ 4.6%
Debt €131.30M ▼ 7.4%
Debt's share of the balance-sheet total falls from 52.5% to 51.7%. Equity and debt are lower.
Key figures and ratios
2024 value · change against 2023
ROE
-4.8%▼
2023 · -1.5%
ROA
-2.3%▼
2023 · -0.7%
Debt ≤ 1 year
€1.03M▲
2023 · €564k
Debt > 1 year
€128.41M▼
2023 · €136.95M
Income taxes
€30k▲
2023 · €25k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 61 lines
Balance sheet Code20232024
Assets
Total assets20/58€270.31M€253.86M▼
Fixed assets21/28€254.17M€239.00M▼
Intangible fixed assets21-€65k
Financial fixed assets28€254.17M€238.93M▼
Affiliated companies280/1€254.17M€238.93M▼
Participating interests280€147.18M€147.18M=
Amounts receivable281€106.98M€91.75M▼
Current assets29/58€16.14M€14.86M▼
Amounts receivable within one year40/41€5.57M€4.82M▼
Trade receivables40€3.36M€2.76M▼
Other amounts receivable41€2.21M€2.07M▼
Current investments50/53€4.00M€9.90M▲
Other investments51/53€4.00M€9.90M▲
Cash at bank and in hand54/58€6.41M€91▼
Deferred charges and accrued income490/1€165k€142k▼
Equity and liabilities
Total equity and liabilities10/49€270.31M€253.86M▼
Equity10/15€128.48M€122.56M▼
Contributions10/11€143.28M€143.28M=
Capital10€143.27M€143.27M=
Issued capital100€143.27M€143.27M=
Outside capital11€8k€8k=
Share premium1100/10€8k€8k=
Reserves13€513k€513k=
Non-distributable reserves130/1€30k€30k=
Legal reserve130€30k€30k=
Distributable reserves133€483k€483k=
Profit (loss) carried forward14€-15.31M€-21.23M▼
Amounts payable17/49€141.83M€131.30M▼
Amounts payable after more than one year17€136.95M€128.41M▼
Financial debts170/4€136.95M€128.41M▼
Other loans174€136.95M€128.41M▼
Amounts payable within one year42/48€564k€1.03M▲
Trade debts44€564k€1.03M▲
Suppliers440/4€564k€1.03M▲
Accrued charges and deferred income492/3€4.32M€1.86M▼
Income statement Code20232024
Operating income70/76A€11.75M€12.40M▲
Turnover70€11.43M€11.99M▲
Other operating income74€31k-
Non-recurring operating income76A€282k€413k▲
Operating charges60/66A€13.37M€13.54M▲
Services and other goods61€13.37M€13.49M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630-€7k
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€40k
Other operating charges640/8€960€1k▲
Operating profit (loss)9901€-1.63M€-1.14M▲
Financial income75/76B€10.52M€6.61M▼
Recurring financial income75€10.52M€6.61M▼
Income from financial fixed assets750€10.52M€6.61M▼
Other financial income752/9€1k€8k▲
Financial charges65/66B€10.86M€11.37M▲
Recurring financial charges65€10.86M€11.37M▲
Debt charges650€10.85M€11.36M▲
Other financial charges652/9€8k€9k▲
Profit (loss) for the period before taxes9903€-1.96M€-5.89M▼
Income taxes67/77€25k€30k▲
Taxes670/3€25k€50k▲
Tax adjustments and reversals of tax provisions77-€21k
Profit (loss) for the period9904€-1.99M€-5.92M▼
Profit (loss) for the period to be appropriated9905€-1.99M€-5.92M▼
Appropriation of the result
Profit (loss) to be appropriated9906€-15.31M€-21.23M▼
Profit (loss) brought forward from the previous period14P€-13.32M€-15.31M▼

The notes to these accounts (40 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2026
30-03
State Gazette act Registered office · Capital & shares · Statutes amendment
Capital increase · Share issue · Capital6 facts ▸
  • General meeting, 29 januari 2026
  • Capital increase, €12.000.000
  • Share issue, aandelen op naam, 16155
  • Capital, €174.805.932,67
  • Statutes amendment
  • Power of attorney, VISION HEALTHCARE
03-03
State Gazette act Registered office
Registered-office move2 facts ▸
  • General meeting, 01-02-2026
  • Registered-office move, Nijverheidslaan 3 te 8560 Gullegem
2025
07-10
State Gazette act Capital & shares · Statutes amendment
Capital increase · Share issue · Capital5 facts ▸
  • General meeting, 09-09-2025
  • Capital increase, €19.224.933,08
  • Share issue, aandelen op naam, 28020
  • Capital increase, €311.349,64
  • Capital, €162.805.932,67
15-05
NBB filing Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
State Gazette act Reappointment: PwC Bedrijfsrevisoren BV (statutory auditor)
Permanent representatives: outer Coppens, Deconinck Matthias and Cools Geert · Resignation: OKAVANGO BV (director) · Appointment: CITINI BV (director)10 facts ▸
  • General meeting, 20-04-2023
  • Auditor reappointment, PwC Bedrijfsrevisoren BV (statutory auditor)
  • General meeting, 18-04-2024
  • Permanent representative, outer Coppens
  • General meeting, 01-11-2024
  • Director resignation, OKAVANGO BV (director)
  • Director discharge, OKAVANGO BV
  • Director appointment, CITINI BV (director)
  • Permanent representative, Deconinck Matthias
  • Permanent representative, Cools Geert
23-08
NBB filing Annual accounts filed
fiscal year 2023 · full schema · 23 days late
2023
21-08
NBB filing Annual accounts filed
fiscal year 2022 · full schema · 21 days late
2022
31-12
Financial Back to profitnet €1.43M
Net result €1.43M after one loss-making year.
31-12
Financial Liquidity times 7current ratio 24.18
Current ratio from 3.72 to 24.18; short-term debt falls from €2.90M to €439k.
20-10
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Power of attorney5 facts ▸
  • General meeting, 04-10-2022
  • Capital increase, €4.500.012,29
  • Capital increase, €4.500.012,29
  • Capital, €143.269.649,95
  • Power of attorney, VISION HEALTHCARE
30-09
State Gazette act Permanent representative: Peter Opsomer
2 facts ▸
  • General meeting, 20-05-2022
  • Permanent representative, Peter Opsomer
01-06
NBB filing Annual accounts filed
fiscal year 2021 · full schema
Show earlier events
2021
31-12
Financial Weakest financial yearnet €-14.75M ▼1454%
Net result drops to €-14.75M, the lowest in the series; recovery starts the following year.
31-12
Financial Equity above €100MEq €120.04M ▲40.6%
Equity rises from €85.36M to €120.04M.
13-12
State Gazette act Resignation: Damier NV (director)
Appointments: Brandracer BV (director) and PwC Sedrijfsrevisoren SV (statutory auditor) · Mandate compensation7 facts ▸
  • General meeting, 01-12-2021
  • Director resignation, Damier NV (director)
  • Director appointment, Brandracer BV (director)
  • Mandate compensation, Brandracer BV
  • Auditor appointment, PwC Sedrijfsrevisoren SV (statutory auditor)
  • Board composition, Okavango BV (director)
  • Board composition, Brandracer BV (director)
19-07
State Gazette act Statutes amendment
Capital increase · Share issue · Capital5 facts ▸
  • General meeting, 30-06-2021
  • Capital increase, €7.979.319,79
  • Share issue, nieuwe volledig gestorte aandelen, 23654
  • Capital, €134.269.625,37
  • Statutes amendment
12-07
State Gazette act Capital & shares
Capital increase · Capital · Power of attorney5 facts ▸
  • General meeting, 30-06-2021
  • Capital increase, €18.989.816,18
  • Capital, €126.290.305,58
  • Power of attorney, VISION HEALTHCARE
  • Power of attorney, Kurt Vuylsteke
16-06
NBB filing Annual accounts filed
fiscal year 2020 · full schema
15-06
State Gazette act Capital & shares
Capital increase · Capital · Power of attorney4 facts ▸
  • General meeting, 01-06-2021
  • Capital increase, €22.465.586,4
  • Capital, €107.300.489,4
  • Power of attorney, bestuurders
2020
31-12
Financial Back to profitnet €1.09M
Net result €1.09M after one loss-making year.
31-12
Financial Equity above €50MEq €85.36M ▲170%
Equity rises from €31.56M to €85.36M.
24-09
State Gazette act Resignation: The Advice Company Comm.V. (director)
1 fact ▸
  • Director resignation, The Advice Company Comm.V. (director)
16-07
State Gazette act Resignations: Damier, Okavango and 7 others
Appointments: Damier, Okavango and The Advice Company · Permanent representatives: VINDEVOGEL Yvan Valère, LEMAIRE Bernard Jean and 5 others · Statutes amendment35 facts ▸
  • General meeting, 18-06-2020
  • Statutes amendment
  • Statutes amendment
  • Capital, €84.834.903
  • Director resignation, Damier (director)
  • Director resignation, Okavango (director)
  • Director resignation, Thierry Bogaert (director)
  • Director resignation, ADC Consult (director)
  • Director resignation, VAN RAPPARD Teun (director)
  • Director resignation, Creafund (director)
  • Director resignation, Casa Damier (director)
  • Director resignation, VINDEVOGEL Edouard (director)
  • +23 further facts in this act
25-06
State Gazette act Capital & shares · Resignations & appointments
Share issue · Capital · Power of attorney9 facts ▸
  • Share issue, B, 6073
  • Capital, €84.834.903
  • Power of attorney, Matthias Deconinck
  • Power of attorney, Matthieu Maselis
  • Material error correction, EUR, 72750088.64
  • Share class breakdown, 287896, 34964
  • Dividend entitlement, dividendgerechtigd voor het volledig lopend boekjaar
  • Issue price
  • Subscription price allocation, EUR, 614698.0
03-06
State Gazette act Statutes amendment · Resignations & appointments
Statutes amendment · Capital · Board composition8 facts ▸
  • General meeting, 11-05-2020
  • Statutes amendment
  • Statutes amendment
  • Capital, €84.202.205
  • Board composition, 9 members: 5 appointed on nomination of Soort A shareholders, 1 by Soort C shareholders, 1 by CreaVision Healthcare B. Maatschap, 2 by the Consortium
  • Transfer restriction, Soort B shareholders may not transfer shares until 22 February 2023; Soort C shareholders may not transfer shares until 31 December 2021
  • External representation, The company is validly represented by two directors, at least one of whom is a Soort A director, acting jointly
  • Shareholders agreement, Shareholders' agreement dated 2 April 2019
92.2% of this act was read; anything after the cut is not in this list.Read the act at the Belgisch Staatsblad ↗
25-05
NBB filing Annual accounts filed
fiscal year 2019 · full schema
25-05
NBB filing Annual accounts filed
fiscal year 2019 · consolidated
27-03
State Gazette act Resignation: Yvan Vindevogel (director)
Appointment: Edouard Vindevogel (director) · Permanent representative: Herman Wielfaert4 facts ▸
  • General meeting, 28-02-2020
  • Director resignation, Yvan Vindevogel (director)
  • Director appointment, Edouard Vindevogel (director)
  • Permanent representative, Herman Wielfaert
2019
11-12
State Gazette act Appointments: Casa Damier BVBA, Henri Vindevogel and 2 others
Permanent representatives: Catherine Debal and Anthony De Clerck7 facts ▸
  • General meeting, 24-06-2019
  • Director appointment, Casa Damier BVBA (director)
  • Permanent representative, Catherine Debal
  • Director appointment, Henri Vindevogel (director)
  • Director appointment, Anthony Teun Ridder van Rappard (director)
  • Director appointment, ADC Consult Comm.V. (director)
  • Permanent representative, Anthony De Clerck
22-07
NBB filing Annual accounts filed
fiscal year 2018 · consolidated
18-07
NBB filing Annual accounts filed
fiscal year 2018 · full schema
09-04
State Gazette act Capital & shares
Capital increase · Capital · Statutes amendment7 facts ▸
  • General meeting, 02-04-2019
  • Capital increase, €23.530.676,64
  • Capital increase, €11.469.323,36
  • Capital, €84.202.205
  • Statutes amendment
  • Approval, verslagen van de raad van bestuur en van de commissaris
  • Power of attorney, Raad van bestuur
05-04
State Gazette act Miscellaneous
General meeting1 fact ▸
  • General meeting, 11-02-2019
26-02
State Gazette act Appointments: PwC Bedrijfsrevisoren (statutory auditor) and CREAFUND (director)
Permanent representative: H&H CAPITAL MANAGEMENT · Capital increase · Capital19 facts ▸
  • General meeting, 14-02-2019
  • Auditor appointment, PwC Bedrijfsrevisoren (statutory auditor)
  • Capital increase, €7.450.579,69
  • Capital increase, €4.834.020,31
  • Capital, €49.220.205
  • Statutes amendment
  • Share transfer, Georges Van Nevel → Stichting Administratiekantoor Vision Healthcare
  • Share transfer, Alain Duperray → Stichting Administratiekantoor Vision Healthcare
  • Share transfer, Koen Van Elverdinghe → Stichting Administratiekantoor Vision Healthcare
  • Share transfer, Kristen Schrijvers → Stichting Administratiekantoor Vision Healthcare
  • Director appointment, CREAFUND (director)
  • Permanent representative, H&H CAPITAL MANAGEMENT
  • +7 further facts in this act
18-02
State Gazette act Capital & shares
Capital increase · Capital · Statutes amendment6 facts ▸
  • General meeting, 13-02-2019
  • Capital increase, €2.856.499
  • Capital increase, €2.143.501
  • Capital, €36.935.605
  • Statutes amendment
  • Power of attorney, Raad van bestuur
2018
16-10
State Gazette act Appointment: Ilse De Baets (statutory auditor)
Capital increase · Capital · Share transfer9 facts ▸
  • General meeting, 11-10-2018
  • Auditor appointment, Ilse De Baets (statutory auditor)
  • Capital increase, €246.500
  • Capital increase, €168.805
  • Capital, €31.935.605
  • Share transfer, Johan De Loor → Stichting Administratiekantoor Vision Healthcare
  • Share transfer, Thomas Wallace → Stichting Administratiekantoor Vision Healthcare
  • Share transfer, Philip Prosser → Stichting Administratiekantoor Vision Healthcare
  • Power of attorney, Raad van bestuur Vision Healthcare
19-06
State Gazette act Appointment: BV ovve CVBA PwC Bedrijfsrevisoren (statutory auditor)
Permanent representative: Ilse De Baets · Approval4 facts ▸
  • General meeting, 29-05-2018
  • Approval
  • Auditor appointment, BV ovve CVBA PwC Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Ilse De Baets
30-03
State Gazette act Resignation: VISION HEALTHCARE (director)
Appointments: DAMIER, OKAVANGO and 2 others · Permanent representatives: VINDEVOGEL Yvan Valère Marguerite and LEMAIRE Bernard Jean Yvon Marie Hubert · Capital increase18 facts ▸
  • General meeting, 22-02-2018
  • Capital increase, €25.345.300
  • Capital increase, €4.925.000
  • Capital, €31.520.300
  • Director resignation, VISION HEALTHCARE
  • Director appointment, DAMIER (director)
  • Permanent representative, VINDEVOGEL Yvan Valère Marguerite
  • Director appointment, OKAVANGO (director)
  • Permanent representative, LEMAIRE Bernard Jean Yvon Marie Hubert
  • Director appointment, VINDEVOGEL Yvan Valère Marguerite (director)
  • Director appointment, THIERRY BOGAERT (director)
  • Permanent representative, LEMAIRE Bernard Jean Yvon Marie Hubert
  • +6 further facts in this act
2017
14-12
State Gazette act Incorporation
Appointments: DAMIER (director) and OKAVANGO (director) · Permanent representatives: VINDEVOGEL Yvan Valère Marguerite and LEMAIRE Bernard Jean Yvon Marie Hubert · Founding capital10 facts ▸
  • Incorporation, 11-12-2017
  • Founding capital, €1.250.000
  • Director appointment, DAMIER (director)
  • Director appointment, OKAVANGO (director)
  • Permanent representative, VINDEVOGEL Yvan Valère Marguerite
  • Permanent representative, LEMAIRE Bernard Jean Yvon Marie Hubert
  • Director appointment, DAMIER (chair of the board)
  • Director appointment, DAMIER (managing director)
  • Founder, DAMIER
  • Founder, LEMAIRE Bernard Jean Yvon Marie Hubert
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
8 directors, last change in 2024
CITINI BV
Director · since 01-11-2024 · Legal entity · perm. rep.: Deconinck Matthias
Current
BRANDRACER
Director · since 01-12-2021 · Private limited company
Current
Damier
Director · since 18-06-2020 · Legal entity · perm. rep.: VINDEVOGEL Yvan Valère Marguerite
Not recently confirmed
OKAVANGO
Director · since 18-06-2020 · Private limited company · perm. rep.: LEMAIRE Bernard Jean Yvon Marie Hubert
Not recently confirmed
THE ADVICE COMPANY
Director · since 18-06-2020 · Limited partnership · perm. rep.: DOBBELAERE Bart
Not recently confirmed
Anthony Teun Ridder van Rappard
Director · since 05-06-2019
Not recently confirmed
2 other directors
THIERRY BOGAERT
Director · since 22-02-2018 · Legal entity · perm. rep.: LEMAIRE Bernard Jean Yvon Marie Hubert
Not recently confirmed
DAMIER
Director · since 11-12-2017 · Public limited company · perm. rep.: VINDEVOGEL Yvan Valère Marguerite
Not recently confirmed
01-11-2024 CITINI BV: Appointed as Director
01-11-2024 OKAVANGO BV: Resigned as Director
01-12-2021 BRANDRACER: Appointed as Director
01-12-2021 DAMIER NV: Resigned as Director
01-09-2020 The Advice Company Comm.V.: Resigned as Director
Full history in the Timeline (31 changes) →
Not every act has been read: a resignation may be missing here
1 act was read only in part. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Wevelgem · 1 establishment unit since 2018
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Nijverheidslaan 38560 Wevelgem
Ground area
1.3 ha
Building footprint
8,072 m²
Volume, LiDAR
37,591 m³
Parcel 34012A0428/02P002, Flanders · tallest building 9.5 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Vision Healthcare NV
Nijverheidslaan 3, 8560 WevelgemRetail sale of cosmetics and toilet articles
since 20182.275.095.111
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
34012A0428/02P002 Flanders 1.3 ha 1 · 8,072 m² 9.5 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Statutory auditor

1 auditor
BV PwC BedrijfsrevisorenCurrent
Statutory auditor · represented by outer Coppens
20-04-2023 → present
Show 4 earlier auditors
BV ovve CVBA PwC Bedrijfsrevisoren
Statutory auditor · represented by Ilse De Baets
succeeded by PwC Sedrijfsrevisoren SV in 2021
29-05-2018 → 21-04-2021
Ilse de Baets
Statutory auditor
succeeded by PwC Sedrijfsrevisoren SV in 2021
11-10-2018 → 21-04-2021
Pwc Bedrijfsrevisoren
Statutory auditor
succeeded by PwC Sedrijfsrevisoren SV in 2021
14-02-2019 → 21-04-2021
PwC Sedrijfsrevisoren SV
Statutory auditor
succeeded by BV PwC Bedrijfsrevisoren in 2023
21-04-2021 → 20-04-2023

Articles of association

Purpose
De vennootschap heeft tot voorwerp, zowel in België als in het buitenland, voor eigen rekening of voor rekening van derden of door deelneming: I. Specifieke activiteiten. A/ het…
Full purpose

De vennootschap heeft tot voorwerp, zowel in België als in het buitenland, voor eigen rekening of voor rekening van derden of door deelneming: I. Specifieke activiteiten. A/ het fabriceren, verdelen en verkopen... [full text omitted for brevity in thought, included in quote]

according to the deed of 16-07-2020

Structure & network

Connections & network

7 connected companies
Beddeleem, Shared corporate director BBeddeleemDOMO INVESTMENT GROUP, Shared corporate director DIDOMO INVESTMENTGROUPEUROPEAN FUTURE STRUCTURES, Shared corporate director EFEUROPEAN FUTURESTRUCTURESGeorges Veldeman, Shared corporate director GVGeorgesVeldemanPerrigo Holding, Shared corporate director PHPerrigoHoldingPurna Pharmaceuticals, Shared corporate director PPPurnaPharmaceuticalsSAJAMA, Shared corporate director SSAJAMAVISION HEALTHCARE VISIONHEALTHCARE0685.849.188
Shared directors
Linked via shared directors
Beddeleem
Shared corporate director
→
DOMO INVESTMENT GROUP
Shared corporate director
→
EUROPEAN FUTURE STRUCTURES
Shared corporate director
→
Georges Veldeman
Shared corporate director
→
Show 3 more companies with a shared director
Perrigo Holding
Shared corporate director
→
Purna Pharmaceuticals
Shared corporate director
→
SAJAMA
Shared corporate director
→

Ownership & control

1 subsidiary, 1 abroad
VISION HEALTHCAREBE 0685.849.188
controls
Where this company holds controlsubsidiary per the LEI register1
VISION HEALTHCARE B.V.
Haarlem, Netherlands · LEI lapsed

Capital and shareholders

Shareholders according to the acts
Share transfer act of 26-02-2019 ↗
  • Georges Van Nevel to Stichting Administratiekantoor Vision Healthcare 2,094 shares
  • Alain Duperray to Stichting Administratiekantoor Vision Healthcare 1,745 shares
  • Koen Van Elverdinghe to Stichting Administratiekantoor Vision Healthcare 1,745 shares
  • Kristen Schrijvers to Stichting Administratiekantoor Vision Healthcare 1,745 shares
Share transfer act of 16-10-2018 ↗
  • Johan De Loor to Stichting Administratiekantoor Vision Healthcare 1,000 shares
  • Thomas Wallace to Stichting Administratiekantoor Vision Healthcare 1,816 shares
  • Philip Prosser to Stichting Administratiekantoor Vision Healthcare 649 shares
At incorporation act of 14-12-2017 ↗
  • DAMIER (BE 0445.703.716) founder
  • LEMAIRE Bernard Jean Yvon Marie Hubert founder

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 30-03-2026 Capital increase of 12,000,000 EUR · to 174,805,932.67 EUR · 16,155 new shares · in kind
  2. 07-10-2025 Capital increase of 19,224,933.08 EUR · to 162,494,583.03 EUR · 28,389 new shares · in kind
  3. 07-10-2025 Capital increase of 311,349.64 EUR · to 162,805,932.67 EUR · 460 new shares · in cash
  4. 20-10-2022 Capital increase of 4,500,012.29 EUR · to 138,769,637.66 EUR · 6,472 new shares · in cash
  5. 20-10-2022 Capital increase of 4,500,012.29 EUR · to 143,269,649.95 EUR · 6,472 new shares · in kind
  6. 19-07-2021 Capital increase of 7,979,319.79 EUR · to 134,269,625.37 EUR · 23,654 new shares · in kind
  7. 12-07-2021 Capital increase of 18,989,816.18 EUR · to 126,290,305.58 EUR · 56,294 new shares
  8. 15-06-2021 Capital increase of 22,465,586.40 EUR · to 107,300,489.40 EUR · 66,598 new shares
Show 13 older capital entries
  1. 16-07-2020 Capital stated in 2 acts · 84,834,903 EUR · 620,863 shares
  2. 03-06-2020 Capital stated in the act · 84,202,205 EUR · 614,790 shares
  3. 09-04-2019 Capital increase of 23,530,676.64 EUR · to 72,732,881.64 EUR · 198,898 new shares · in cash
  4. 09-04-2019 Capital increase of 11,469,323.36 EUR · to 84,202,205 EUR · no new shares · “inlijving van de onbeschikbare rekening "uitgiftepremies"”
  5. 26-02-2019 Capital increase of 7,450,579.69 EUR · to 44,386,184.69 EUR · 69,810 new shares · in kind
  6. 26-02-2019 Capital increase of 4,834,020.31 EUR · to 49,220,205 EUR · no new shares · inlijving uitgiftepremie
  7. 18-02-2019 Capital increase of 2,856,499 EUR · to 34,792,104 EUR · 28,414 new shares · in cash
  8. 18-02-2019 Capital increase of 2,143,501 EUR · to 36,935,605 EUR · no new shares · “inlijving van de onbeschikbare rekening "uitgiftepremies"”
  9. 16-10-2018 Capital increase of 246,500 EUR · to 31,766,800 EUR · 2,465 new shares · in kind
  10. 16-10-2018 Capital increase of 168,805 EUR · to 31,935,605 EUR · no new shares · inlijving uitgiftepremie
  11. 30-03-2018 Capital increase of 25,345,300 EUR · to 26,595,300 EUR · 253,453 new shares · in kind
  12. 30-03-2018 Capital increase of 4,925,000 EUR · to 31,520,300 EUR · 49,250 new shares · in cash
  13. 14-12-2017 Incorporation · 1,250,000 EUR

Recognitions · licences · registrations

Legal Entity Identifier

894500VK09R41RI8I706
no longer live in the LEI register

Similar companies · same sector, comparable size

Ipsen
BE 0422.650.477
Brussel · Eq €119.88M
Pfizer
BE 0401.994.823
Elsene · Eq €155.73M
BAXTER
BE 0403.093.693
Lessines · Eq €83.81M
PHYSIOL
BE 0428.242.033
Liège · Eq €78.44M
ODYSSEA PHARMA
BE 0892.121.272
Grâce-Hollogne · Eq €76.39M
Of 148 companies in sector 21201 we hold annual accounts for 116. 33 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification
Legal formPublic limited company
Founded12-12-2017
Fiscal year end31-12
Activities, NACEBEL 2025
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
21209Manufacture of basic pharmaceutical products and pharmaceutical preparations
46460Wholesale of pharmaceutical and medical goods
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
64210Activities of holding companies
Sources
Crossroads Bank for EnterprisesNational Bank · 9 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.

We would like to set cookies. That happens only with your consent. What we measure